To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Merck KGaA v. Integra Lifesciences I, Ltd.
Merck KGaA, Petitioner v. Integra Lifesciences I, Ltd., et al., 545 U.S. 193 (2005), is a United States Supreme Court case with ramifications for patent law. The dispute dates to approximately 1996 and centers on a federal law known as the "FDA safe harbor". Product highlightSee also
References
|
|||||||||||||||||||||||||||
| This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Merck_KGaA_v._Integra_Lifesciences_I,_Ltd.". A list of authors is available in Wikipedia. | |||||||||||||||||||||||||||
- Sars-CoV-2-Mutanten im Wettlauf - Übertragbarkeit von neuen Virus-Mutanten genau bestimmen
- Arterial_tortuosity_syndrome
- Neuromuscular-blocking_drugs
- Analytik verbindet: Austausch über Fachgrenzen hinweg - Forschung trifft Anwendung auf der analytica conference 2024
- Gene Bridges Announces Distribution Agreement with CAMBIO for Red/ET Recombination Kits



